Synthetic studies of enacyloxins (ENXs), a series of yellow-colored, polyene-polyol antibiotics produced by Frateuria sp. W-315, are described. The C1'-C8' polyene fragments were prepared using successive Wittig reactions. The C9'-C15' and C10'-C15' fragments were constructed from (S)isopropylideneglyceraldehyde using Yamaguchi's nucleophilic substitution reaction of acetylide to epoxide, and/or Marshall's allenylindium mediated reaction as the key steps.
Enacyloxin IIa (ENX IIa, 1) is one of a series of antibiotic enacyloxins (ENXs) produced from Frateuria sp. W-315 in a Czapek-Dox medium spent by Neurospora crassa (Scheme 1) [1] . ENXs exhibit antibiotic activities against Gram-positive and Gramnegative bacteria through inhibition of peptide biosynthesis by hindering the release of EF-Tu GDP from the ribosome [1] [2] [3] . Spectroscopic analysis and synthetic studies by our group [4] , and X-ray crystallographic analysis by Permeggiani [3] elucidated the stereochemistry of ENXs. We have made efforts to synthesize ENXs according to the retrosynthesis shown in Scheme 1, and the synthesis of the cyclohexane D [4a,5] , C9'-C15' [6] , and C16'-C23' fragments [7] have been reported. As a continuation of our synthetic studies, the preparation of the C1'-C8' C and the improved synthesis of the C9'-C15', corresponding to B, fragments are described in this short communication.
The synthesis of C1'-C8' fragments started from the known ester 4 [8] derived from but-2-ene-1,4-diol (2), and a Wittig reagent 3 (Scheme 2). Reduction of 4 gave an allylic alcohol 5 [9] and partial oxidation of the newly formed hydroxy group afforded aldehyde 6 [10] . Reaction of the aldehyde 6 with a Wittig reagent 7 gave 8, and elongation of the two carbon chain was accomplished by a similar reaction sequence to form the triene ester, C1'-C8' carbon framework, 9. Then hydrolytic removal of the THP group under mildly acidic conditions gave 10 [11] , and its bromination afforded 11. Treatment of the bromide 11 with sodium p-toluenesulfinate led to sulfone 12 in low yield, while triethyl phosphite furnished Wittig reagent 13 via Arbusov rearrangement quantitatively. The ENX C1'-C8' fragments 12 and 13 were synthesized as nucleophiles.
Only the (E,E,E)-isomer was detected on the 1 H NMR spectrum.
Although the synthesis of C9'-C15' fragment B had been achieved [6] , it had started with expensive diethyl D-tartrate and the synthetic scheme was not reproducible. Thus, we changed the strategy using easily available D-glyceraldehyde derivative 14 (Scheme 3). We chose (Z)-alkene 15 prepared from 14 [12] for the synthetic studies of the C9'-C15' fragment. Epoxidation of 15 by MCPBA was not diastereoselective, thus the acetonide protecting group of 15 was removed in order to use the steric control of a free hydroxy group (16) [13] . As planned, treatment of 16 with MCPBA gave synepoxide 17 as a single isomer. The vicinal hydroxy groups of 17 were protected as an acetonide again to afford the coupling partner 18. Nucleophilic substitution of 18 with O-TBDPS protected propargyl alcohol 19 using Yamaguchi's method [14] gave the C9'-C15' fragment 20 with desired stereochemistry. However, the yield was low. This was presumed to be due to the bulkiness of the TBDPS group of 19 so the nucleophile was changed with TMSacetylene (21). In this case, the C10'-C15' fragment 22 was obtained as a single isomer in 40% yield. The stereochemistry of 20 and 22 was attributed by the stereospecific reaction mechanisms shown by Marshall's group [15, 16] . This was also elucidated by comparing the 1 H-NMR spectral data of the corresponding 13',14'-O,O-acetonide derivative with that of our reported compound [6] .
We also tried allene chemistry to construct the R-stereochemisty of the C25'-methyl group attached to C12' developed by the Marshall group (Scheme 4). Accordingly, propargylic mesylate 24 [17] , prepared from ethyl (S)-lactate 23, was subjected to Marshall conditions using Pd(OAc) 2 , Ph 3 P, Et 2 Zn [15] , and 14; however, product 25 was not formed. Use of aldehyde 26 [18] also failed. We thought this result was due to the bulkiness of the pivaloyl (Piv) protecting group of 24. Thus, we chose mesylate 28, derived from 27 via enzymatic resolution [16] , which possesses an electron donating trimethylsilyl (TMS) substituent on the terminal alkyne position. In addition, by using indium iodide, Marshall coupling of 28 with 14 afforded the C9'-C15' fragment 22 as a single isomer. In conclusion, we have synthesized the C1'-C8' triene fragment of ENXs using Wittig reaction as the key steps, while, the C9'-C15' and C10'-C15' fragments were prepared by the Yamaguchi and/or Marshall methods. Coupling between these fragments towards total synthesis is underway.
Experimental
General: 1 H NMR spectra were recorded with a Varian 400 MR (400 MHz) spectrometer in CDCl 3 with CHCl 3 (δ H 7.26 ppm) as an internal standard. Merck silica gel 60 (70-230 mesh) was used for column chromatography. Merck silica gel 60 F254 (0.25 mm and 0.50 mm thickness) was used for analytical and preparative TLC, respectively.
Ethyl
( 2E,4E,6E)-8-(diethoxyphosphoryl)-6-methylocta-2,4,6trienoate (13) : To a solution of 10 (MW: 196.24, 640 mg, 3.26 mmol) in dry Et 2 O (25 ml) was added, dropwise, PBr 3 (0.32 mL, 3.5 mmol) at 0°C, and the mixture was stirred for 5 min at 0°C. Then, to this was Synthetic studies of enacyloxins Natural Product Communications Vol. 10 (4) 2015 647 added sat. aq. NaHCO 3 soln., and the mixture was extracted with diethyl ether. The organic layer was dried (Na 2 SO 4 ) and concentrated in vacuo to give crude bromide 11 as a pale yellow oil. This was used in the next step without further purification.
The crude 11, dissolved in P(OEt) 3 (7.0 mL, 8.6 g, 41 mmol), was stirred under reflux (130°C) for 19 h. The resultant solution was concentrated in vacuo. The residue was purified by flash CC to provided 13 (MW: 316.33, 1.03 g, 3.26 mmol, quantitative). (2R,3Z)-Pent-3-ene-1,2-diol (16) ( 2R,3S,4R)-3,4-Epoxypentane-1,2-diol (17) : To a solution of 16 (0.76 g, 7.4 mmol), NaHCO 3 (0.75 g, 1.2 eq.), and MS4A in CH 2 Cl 2 (80 mL) half of MCPBA (1.9 g, 1.2 mmol) in CH 2 Cl 2 (30 ml) was added, dropwise, and warmed to 0°C then recooled to -78°C. Another half of reactant was added, dropwise, and warmed to 0°C. The solution was filtered through a celite pad and concentrated under reduced pressure to give 17 (MW: 118.13, ca. 580 mg, ca. 4.9 mmol, ca. 66%), which was used in the next step without purification due to its high hydrophilicity.
( 2R,3R,4R)-3,4-Epoxy-1,2-isopropylidenedioxypentane (18) : To a solution of 17 (ca. 580 mg, ca. 4.9 mmol) and 2,2-dimethoxypropane (0.61 mmol, 10 eq.) in DMF (1.0 mL), PPTS (6.3 mg, 5.0 mol%) was added at 0°C and the mixture was stirred at 20°C overnight. To this was then added sat. aq. NaHCO 3 soln. and extracted with diethyl ether. The combined organic layer was washed with water, dried (MgSO 4 ) and ( 2R,3R,4R)-7-tert-Butyldiphenylsilyloxy-1,2-isopropylidenedioxy-4methylhept-5-yn-3-ol (20) : To a solution of 19 (MW: 294.46, 87 mg, 0.30 mmol, 10 eq.) in THF (2.0 mL) was added, dropwise, BuLi (1.6 M in n-hexane, 0.19 mL, 0.30 mmol) with stirring and the mixture was warmed to -10°C. After being stirred for 30 min at -10°C, the mixture was cooled to -78°C. Then, to the solution was added carefully boron trifluoride etherate (42 mg, 0.30 mmol) and the mixture was stirred for 20 min. To this was added a solution of 18 (4.7 mg, 0.030 mmol) in THF (2.0 mL) and the mixture was stirred at -78°C overnight. To this was added sat. aq. NH 4 Cl soln. and extracted with EtOAc. The combined organic layer was dried (MgSO 4 ) and concentrated in vacuo. The residue was purified by preparative TLC to give 20 (MW: 452.66, 2.4 mg, 0.0054 mmol, 18%) as a colorless oil. 
(2R,3R,4R)-1,2-Isopropylidenedioxy-4-methyl-6-trimethylsilylhex-5yn-3-ol (22):
In a similar manner as described for 20, 18 (11 mg, 0.070 mmol) and 21 (MW: 98.21, 140 mg, 1.4 mmol) were converted to 22 (MW: 256.41, 7.2 mg, 0.028 mmol, 40%) as a colorless oil. 
